Sleep Appliances In Shreveport, LA
Correct your sleep apnea with an oral device.
Full Service Dentistry
Several oral devices, including a tongue-retaining device worn while sleeping, have been tested to treat snoring and sleep apnea. It improves airflow by pushing the tongue and jaw forward. The lower jaw can be moved to expand the airway and reduce the chances of it collapsing as you inhale. This could help you stop snoring. A mandibular repositioning device is what this equipment is named.
Some oral breathing devices stimulate the throat muscles with electricity to keep the airway from collapsing as you sleep. Oral breathing devices have been shown to reduce snoring in studies.
Oral appliances are most useful in the treatment of mild to moderate sleep apnea, but they can also be used in the treatment of severe OSA patients who cannot or will not tolerate positive airway pressure therapy. Oral appliances, despite their double-retainer-like look, are claimed to be comfortable to wear. An oral appliance and CPAP are sometimes used together to treat more severe sleep apnea.
Oral devices to treat OSA are not available over the counter in the United States. They must be prescribed by a physician and fitted by a sleep medicine-trained dentist, oral surgeon, or ENT.
Here at Dr. Chris A Mott DDS, we offer effective sleep appliances in Shreveport, LA, that can resolve as well as help avoid several problems.
What we recommend:
The Silent Nite® by Glidewell
We help patients achieve a deeper, more satisfying night’s sleep using the Silent Night Sleep Appliance from Glidewell. The Silent Nite Sleep Appliance is flexible, thin and comfortable, and it exhibits documented clinical success in mitigating or preventing the disruptive, unhealthy effects of snoring and mild to moderate sleep apnea. The Silent Nite appliance is designed to gently shift the lower jaw forward in a therapeutic position during sleep. This activates the airway muscles and ligaments to prevent the airway from collapsing. Each Silent Nite case includes extra connectors, in various sizes, and an AM Aligner to aid patients in exercising and realigning the jaw after nighttime mandibular advancement.
Oral appliance therapy (OAT) is very effective in treating patients with sleep-disordered breathing, with a compliance rate shown to be as high as 90% over a 2.5-year period.1
OAT is associated with greater patient satisfaction than nasal continuous positive airway pressure (CPAP) therapy.2
In a randomized crossover trial comparing OAT to CPAP in patients with obstructive sleep apnea, about 81% preferred OAT.3
Among patients with obstructive sleep apnea, both continuous positive airway pressure (CPAP) and mandibular advancement devices (MADs) were associated with reductions in blood pressure. Network meta-analysis did not identify a statistically significant difference between the blood pressure outcomes associated with these therapies.4
A mandibular advancement device for obstructive sleep apnea reduces nocturnal blood pressure in women.5
- Yoshida K. Effects of a mandibular advancement device for the treatment of sleep apnea syndrome and snoring on respiratory function and sleep quality. Cranio. 2000 Apr;18(2):98-105.
- Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs. nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest. 1996 May;109(5):1269-75.
- Tan YK, L’Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, Spiro SG, Battagel JM. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod. 2002 Jun;24(3):239-49.
- Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs. mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015 Dec 1;314(21):2280-93.
- Rietz H, Franklin KA, Carlberg B, Sahlin C, Marklund M. Nocturnal blood pressure is reduced by a mandibular advancement device for sleep apnea in women: findings from secondary analyses of a randomized trial. J Am Heart Assoc. 2018 Jun 21;7(13).